NA
ATRC icon

NewEdge Advisors’s AtriCure ATRC Stock Holding History

NewEdge Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10
Closed -$228 – 3820
2024
Q2 		$228 Sell
10
-188
-95% -$4.34K ﹤0.01% 3638
2024
Q1 		$6.02K Sell
198
-273
-58% -$9.14K ﹤0.01% 3072
2023
Q4 		$16.8K Buy
+471
New +$17.5K ﹤0.01% 2642
2023
Q1 		– Sell
-681
Closed -$30.2K – 3458
2022
Q4 		$30.2K Buy
+681
New +$28.4K ﹤0.01% 1957

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

NewEdge Advisors's ATRC Position: Q3 2024 in Review

NewEdge Advisors sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 10 shares — an estimated $228 sold.

NewEdge Advisors first reported a position in ATRC in Q4 2022 and held it in 4 quarters. The position peaked at $30.2K in Q4 2022. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

  • NewEdge Advisors reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
  • NewEdge Advisors sold 10 AtriCure shares in Q3 2024, an estimated $228.
  • NewEdge Advisors first reported a position in AtriCure in Q4 2022 and held it in 4 quarters.
  • NewEdge Advisors's AtriCure position peaked at $30.2K in Q4 2022.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on NewEdge Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.